4-s-(propionic acid)sulfidocyclophosphamide and Pancreatic Neoplasms

4-s-(propionic acid)sulfidocyclophosphamide has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ishii, A; Kataoka, K; Kim, HJ; Lee, Y; Miyata, K; Nishiyama, N; Oba, M; Wu, S	1

Other Studies

1 other study(ies) available for 4-s-(propionic acid)sulfidocyclophosphamide and Pancreatic Neoplasms

Article	Year
Introduction of stearoyl moieties into a biocompatible cationic polyaspartamide derivative, PAsp(DET), with endosomal escaping function for enhanced siRNA-mediated gene knockdown. Journal of controlled release : official journal of the Controlled Release Society, 2010, Jul-14, Volume: 145, Issue:2 Topics: Animals; Biocompatible Materials; Cations; Cell Line, Tumor; Cyclophosphamide; Endosomes; Gene Knockdown Techniques; Genes, bcl-2; Humans; Melanoma, Experimental; Mice; Pancreatic Neoplasms; Plasmids; Polymers; RNA, Small Interfering; Transfection	2010

Article

Year

Introduction of stearoyl moieties into a biocompatible cationic polyaspartamide derivative, PAsp(DET), with endosomal escaping function for enhanced siRNA-mediated gene knockdown.

Journal of controlled release : official journal of the Controlled Release Society, 2010, Jul-14, Volume: 145, Issue:2

Topics: Animals; Biocompatible Materials; Cations; Cell Line, Tumor; Cyclophosphamide; Endosomes; Gene Knockdown Techniques; Genes, bcl-2; Humans; Melanoma, Experimental; Mice; Pancreatic Neoplasms; Plasmids; Polymers; RNA, Small Interfering; Transfection

2010